Barclays
SNY icon

Barclays’s Sanofi SNY Stock Holding History

Barclays’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,300
Closed -$319K – 6180
2020
Q1 		$319K Buy
7,300
+3,700
+103% +$177K ﹤0.01% 3945
2019
Q4 		$181K Sell
3,600
-2,000
-36% -$93.7K ﹤0.01% 5111
2019
Q3 		$259K Sell
5,600
-14,500
-72% -$625K ﹤0.01% 4772
2019
Q2 		$870K Sell
20,100
-81,100
-80% -$3.45M ﹤0.01% 3830
2019
Q1 		$4.48M Buy
101,200
+96,900
+2,253% +$4.15M ﹤0.01% 1743
2018
Q4 		$187K Sell
4,300
-9,100
-68% -$401K ﹤0.01% 4622
2018
Q3 		$599K Buy
13,400
+9,000
+205% +$384K ﹤0.01% 4113
2018
Q2 		$176K Sell
4,400
-89,000
-95% -$3.5M ﹤0.01% 4830
2018
Q1 		$3.74M Buy
93,400
+63,100
+208% +$2.63M ﹤0.01% 1855
2017
Q4 		$1.3M Sell
30,300
-13,500
-31% -$622K ﹤0.01% 2835
2017
Q3 		$2.18M Buy
43,800
+8,100
+23% +$392K ﹤0.01% 2255
2017
Q2 		$1.71M Buy
35,700
+17,000
+91% +$812K ﹤0.01% 2389
2017
Q1 		$846K Sell
18,700
-300
-2% -$12.7K ﹤0.01% 2880
2016
Q4 		$768K Buy
19,000
+13,500
+245% +$532K ﹤0.01% 2987
2016
Q3 		$210K Buy
5,500
+1,700
+45% +$68.2K ﹤0.01% 3933
2016
Q2 		$159K Sell
3,800
-68,600
-95% -$2.81M ﹤0.01% 4093
2016
Q1 		$2.9M Buy
72,400
+53,900
+291% +$2.17M ﹤0.01% 1618
2015
Q4 		$777K Buy
18,500
+4,600
+33% +$212K ﹤0.01% 2829
2015
Q3 		$653K Sell
13,900
-15,200
-52% -$774K ﹤0.01% 3115
2015
Q2 		$1.43M Buy
29,100
+15,500
+114% +$786K ﹤0.01% 2548
2015
Q1 		$666K Sell
13,600
-19,700
-59% -$942K ﹤0.01% 3321
2014
Q4 		$1.5M Buy
33,300
+14,500
+77% +$704K ﹤0.01% 2795
2014
Q3 		$1.05M Buy
18,800
+12,400
+194% +$666K ﹤0.01% 3301
2014
Q2 		$339K Sell
6,400
-3,100
-33% -$165K ﹤0.01% 4340
2014
Q1 		$494K Sell
9,500
-18,400
-66% -$931K ﹤0.01% 3972
2013
Q4 		$1.48M Buy
27,900
+3,400
+14% +$175K ﹤0.01% 2967
2013
Q3 		$1.23M Sell
24,500
-6,500
-21% -$331K ﹤0.01% 3124
2013
Q2 		$1.6M Buy
+31,000
New +$1.65M ﹤0.01% 2793

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Barclays's SNY Position: Q2 2026 in Review

Barclays increased its Sanofi (SNY) stake by 14% in Q2 2026, buying an estimated $14.6M and bringing the position to 2,683,902 shares worth $114M. The position accounts for 0.02% of the portfolio, ranked #464.

Barclays first reported a position in SNY in Q2 2013 and has held it in 53 quarters since. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Barclays held 2,683,902 shares of Sanofi worth $114M as of Q2 2026.
  • Barclays bought 327,343 Sanofi shares in Q2 2026, an estimated $14.6M.
  • Sanofi made up 0.02% of Barclays's portfolio in Q2 2026, its #464 holding.
  • Barclays first reported a position in Sanofi in Q2 2013 and has held it in 53 quarters since.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.